Although confusions persist in what concerns the terminologies used for de-
INTRODUCTION
In 2005, light microscopic evidence was obtained of fibroblastoid stromal cells with long, thin and moniliform processes within the mammary gland (MG) stroma [30] ; such cells were termed at that time interstitial Cajal-like cells (ICLCs). In 2010 the Romanian and Italian researchers renamed these cells from ICLCs to telocytes (TCs), their processes, long of "tens-up to hundreds of [micro] m", being named telopodes [31] . It was unequivocally stated that only transmission electron microscopy (TEM) "allows sure identification of telocytes, evaluation of the cell-tocell interrelationships, and a detailed description of the telopodes" [15] . This attitude was kept until 2014 when it was reinforced that "the features of telocytes are obvious only by transmission electron microscopy" [42] . In these regards, the initial identification of MG ICLCs in light microscopy [30] , which keeps as the only in situ evidence of MG TCs in human tissue, could raise doubts. The only proofs of mammary telocyte-like cells resulted after an in vitro experiment of breast cancer reconstitution performed recently, in which TCs were identified in primary culture cells by phase contrast microscope [25] , no specific marker being used then. Indeed, at this time a specific immune phenotype of TCs was not clearly established [34] ; although the most used markers which point to TCs, but not exclusively, are CD34 and c-kit [15] .
It was only recently indicated by the Italian researchers that "In the adulthood, TC may be considered mesenchymal stromal cells able to differentiate in different cell types, such as the interstitial cells of Cajal, the resident myofibroblasts and the fibroblasts" [43] .
It was also repeatedly stated that TCs "nurse" stem cells (SCs) in the stem cell niches [15, 31, 32, 47] . However, CD34, as well as CD117/c-kit, are well known markers of cells with different levels of stemness [44] . Although CD34 was used for the in vitro study of MG TCs [25] , that antibody was not applied for the in situ evidence of MG ICLCs [30] , further renamed to TCs. Therefore, we aimed at studying by immunohistochemistry the in situ CD34 phenotype of the MG spindle-shaped stromal cells in normal human tissue.
MATERIALS AND METHODS
Human mammary gland samples were obtained after surgery from 8 female patients with ages varying from 46 to 52 years. Informed consent for research use of tissues was obtained prior to surgery. Approval for the present study was granted by the institutional (2nd affiliation, author #1) Bioethics Committee. All experiments on human subjects were conducted in accordance with the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/ b3/index).
Mammary samples were fixed immediately after removal, kept for 24 h in buffered formalin (8%), and then processed with an automatic histoprocessor (Diapath, Martinengo, BG, Italy) with paraffin embedding. Sections were cut manually at 3 μm, and were mounted on SuperFrost ® electrostatic slides for immunohistochemistry (Thermo Scientific, Menzel--Gläser, Braunschweig, Germany).
The following anti-human primary antibodies were used: (a) anti-CD34 (clone QBEnd/10, Biocare Medical, Concord, CA, USA); (b) anti-CD10 (clone 56C6, Biocare Medical, Concord, CA, USA); (c) anti-CD117/c-kit (clone Y145, Biocare Medical, Concord, CA, USA); (d) anti-vimentin (clone SP20, Biocare Medical, Concord, CA, USA).
For CD34 labelling, tissues were deparaffinised and hydrated, then endogenous peroxidase was blocked using Peroxidazed 1 (Biocare Medical, Concord, CA, USA). Carezyme I -Trypsin was used for enzyme digestion. Endogenous biotin was blocked and background blocker was applied to reduce non-specific background staining. The primary antibody was applied at a dilution of 1:100, at room temperature, for 60 min. Then a two-step horseradish peroxidase (HRP) detection method using the 4plus detection system was applied, and a HRP-compatible chromogen diaminobenzidine (DAB) was applied. Sections were counterstained with haematoxylin and rinsed with deionised water. For washing steps was used tris-buffered saline (TBS) solution, pH 7.6.
For CD10 labelling, tissues were deparaffinised and rehydrated, then endogenous peroxidase was blocked using Peroxidased 1 (Biocare Medical, Concord, CA, USA). For the heat induced epitope retrieval was used the Decloaking Chamber (Biocare Medical, Concord, CA, USA) and retrieval solution pH 6 (Biocare Medical, Concord, CA, USA), the latter being a buffer specially formulated for superior pH stability at high temperatures. Background blocker (Biocare Medical, Concord, CA, USA) was used to reduce non-specific background staining. The primary antibody was applied at a dilution of 1:40. As detection system was used MACH 4 (Biocare Medical, Concord, CA, USA) which is a two-step (probe/polymer) universal HRP detection method. A HRP-compatible chromogen (DAB) was applied. Sections were counterstained with haematoxylin and rinsed with deionised water. For washing steps was used TBS solution, pH 7.6.
For CD117/c-kit labelling, tissues were deparaffinised and rehydrated, then endogenous peroxidase was blocked using Peroxidased 1 (Biocare Medical, Concord, CA, USA). For the heat induced epitope retrieval was used the Decloaking Chamber (Biocare Medical, Concord, CA, USA) and retrieval solution pH 6 (Biocare Medical, Concord, CA, USA). Background blocker (Biocare Medical, Concord, CA, USA) was used to reduce non-specific background staining. The primary antibody was applied at a dilution of 1:200. As detection system was used MACH 2 rabbit HRP polymer detection (Biocare Medical, Concord, CA, USA) which consists of a single reagent applied after the primary antibody. A HRP-compatible chromogen (DAB) was applied. Sections were counterstained with haematoxylin and rinsed with deionised water. For washing steps was used TBS solution, pH 7.6.
For vimentin labelling was used the same protocol as for CD117/c-kit, the primary antibody being used at a dilution of 1:200.
RESULTS
The normal structure of the mammary samples was evaluated on the haematoxylin and eosin-stained slides and on the haematoxylin-stained control slides (Figs. 1, 2) . Terminal duct lobular units consisting of terminal ductules, intralobular collecting ducts and the intralobular stroma were separated by fibrous interlobular tissue built-up by densely packed collagen fibres and embedded cells of fibroblastoid shapes. The fibroblastoid cells of the MG stroma presented long and extremely long cell processes serially linking the cells along the collagen bundles (Fig. 1) . Prolongations of the stromal cells were dichotomous (Fig. 2) .
On CD34-labelled slides both the intralobular and interlobular stromal compartments were found rich in immune positive fibroblastoid cells (Figs. 3, 4) with long (tens of micrometres) moniliform cell processes, which were building consistent networks. Being serially linked, these stromal CD34-positive cells ensured cellular paths of stromal transmission of hundreds of micrometres. Although such stromal cells were also neighbouring microvessels they were accurately distinguished of the CD34-positive vascular endothelial cells (Fig. 5) . Moreover, the CD34-positive cells building stromal networks were projecting processes upon the perivascular ones (Fig. 5 ) thus integrating CD10 labelled the ductal myoepithelial cells and also a subset of inter-and intralobular fibroblastoid stromal cells; morphologically identical stromal cells were however CD10-negative (Fig. 6) .
CD117/c-kit labelled the terminal ductules, the luminal cells of the ducts and stromal mast cells; other stromal cells were negative for this antibody (Fig. 7) .
Vimentin labelled the myoepithelial cells of ducts and the microvascular endothelia; the stromal fibroblastoid cells labelling resulted positive (Fig. 8) . 
DISCUSSION
A recent study [6] was focused upon CD34-positive "fibrocytes" of the MG stroma. It was evaluated there the stromal loss of CD34 expression and acquisition of smooth muscle actin phenotype as a condition for invasiveness of breast carcinoma. The authors document there a series of papers referring to the bone marrow-derived circulating fibrocytes firstly described by Bucala et al. [4] , which are defined as acting in reparatory processes and presenting a combined, mesenchymal, haematopoietic and stromal phenotype (e.g.CD34+/CD45+/vimentin and/or collagen I, collagen III, alpha-smooth muscle actin) [36] . The authors distinguish the circulating fibrocytes of constitutional fibrocytes already present within the stromal compartment and available for phenotypic changes during the reparatory processes. The distinction between resident and circulating CD34-positive fibrocytes was clearly indicated by Diaz-Flores et al. [13] , who brought convincing arguments when claiming that CD34-positive stromal fibroblastic/fibrocytic cells are, no matter the different names they were given by different research groups, a subset of stromal cells which "in addition to having the [13] included not only the fibrocytes, but also the TCs, a stromal cell subtype only defined by a morphological pattern: "cells with telopodes" [3, 29] , these later being long, slender and moniliform cell prolongations [37] [38] [39] . Unfortunately, although TCs are consistently investigated, and it was suggested that they could, as well, be either resident, or bone marrow-derived cells with that peculiar morphology [38] , the existing studies did not yet take into account that instead of being "nurses" for the neighbouring stem cells (see also Introduction) TCs could be transit amplifying cells (TACs) deriving from neighbour stem cells, which would justify their positive CD34 and c-kit phenotypes. This is convergent with theories indicating that TCs behave as progenitor cells [11] [12] [13] , thus TACs.
The mammary TCs were initially evaluated exclusively by means of light microscopy, with methylene blue and c-kit stains [30] and were viewed then as c-kit-positive ICLCs. They were not searched then for the CD34 expression. It was documented that, in human chorial villi, some TCs are CD34-positive, some are c-kit-positive [15, 41] . Here a CD34-positive but c-kit-negative phenotype was found. This reinforces the observation of Diaz-Flores et al. (2014) [13] that such stromal cells behave like stem/progenitor cells after losing the CD34 expression. In these regards, the CD34 and the CD117/c-kit phenotypes are reciprocally exclusive in stromal fibroblastoid cells.
Mesenchymal stem cells (MSCs) selectively proliferate to tumours and contribute to the formation of tumour-associated stroma [16] ; bone marrow-derived MSCs cause the cancer cells, in human, to increase their metastatic potency [19] . Except MSCs, adult marrow also contains haematopoietic stem cells (HSCs) and endothelial progenitor cells [1] . To establish a MSC diagnosis, in vitro experiments are needed to evaluate the plastic-adherence of the colonies. Actually, the concept of MSCs is becoming increasingly obscure and the exact identity of MSCs in vivo is not yet clear [21, 24, 35] . On other hand, endothelial progenitor cells usually express c-kit and CD34, a phenotype which was also described for TCs (see Introduction) but was not discussed against a stem cell diagnosis. In this regard, the CD34-positive but CD117/c-kit negative phenotype we found in this study can indicate rejection of an endothelial tip cell diagnosis, HSCs being already rejected when the stromal compartment is observed. This reinforces a mesenchymal stem/progenitor phenotype of the stromal mammary fibroblastoid cells we studied, which is supported by recent experiments in which TCs were found positive for CD29 [3] , a known MSCs marker [26, 46] .
The vimentin-negative phenotype we found for the mammary stromal fibroblastoid cells is able to exclude a diagnosis of circulating fibrocytes and thus to characterise the cell population we studied as resident (constitutional). When TCs pattern was defined [31] cytoskeletal elements, such as thin and intermediate filaments were included; further studies documented the expression of vimentin in TCs [15] . This could equally indicate a progenitor or a fibroblastic phenotype, and does not bring so much in the cell type identification.
The human adipose-derived MSCs result from the stromal vascular fraction of adipose tissue but actually their specific surface markers, morphology and in vivo location are still debated [40] . These cells were found to represent a heterogeneous cell population, most of them constitutively expressing PDGFR and CD10 but variably expressing alpha-SMA, c-kit, Oct4 and CD68 [40] . The expression of CD10 in MSCs was reported either positive, or negative [5, 14, 22, 28, 33] . In the present study, the CD10 expression in the mammary samples was heterogeneous, positive or negative, as compared with the homogenous expression of CD34. This can relate to different stages of acquisition of the MSC phenotype in these cells. The assignment of CD10 only to a subset of MSCs was assessed by an in vitro study [2] . The CD10-positive phenotype was mostly encountered in the vicinity of the mammary vessels and excretory units. This is in accordance with the observations of Kim et al. [20] , in human foetuses, that, similar to CD34, CD10 may be expressed not only in epithelial, but also in juxtaepithelial mesenchymal/ stromal tissues.
We found here multilayered sheaths of CD34-positive stromal cells wrapping around microvessels and excretory units, connected to the CD34-positive stromal networks. Guido Majno pointed in 1965 [18, 23] to cells of the perivascular niche with "protoplasmic expansions wrapped around the vessels". He termed these cells "veil cells" and these were further assumed to serve several main functions, fibrogenesis, phagocytosis, barrier function, and signal conduction [17, 45] . The veil cells of Majno [23] are fibroblastoid cells with a mesenchymal appearance which can be associated with MSCs potentialities [27] . This is consistent with continuously adding evidence which indicate that adult stem niches are, actually, perivascular [7] [8] [9] [10] 48] .
However, further exploration of MG TCs TEM is mandatory, as it could indicate, or not, ultrastructural peculiarities relating the mammary TCs to stem/ /progenitor cells. Of clinical interest remains the MG stromal stem niche contribution in various types of breast cancer; this could be a difficult task, as the contribution of bone marrow to stromal compartments is beyond any doubts and will thus blur a clear identification.
CONCLUSIONS
In conclusion, according to their morphology (e.g. the spindle shape, and the long, slender and moniliform prolongations linking the cells into stromal networks) the CD34+/CD10±/c-kit-/vimentin-cells of the human mammary inter-and intralobular stroma could qualify as being TCs. However, their MSC potentiality is strongly suggested by their immune phenotypes.
